Ethyl 2-(6-chloropyridazin-3-yl)acetate

Catalog No. :
ACXPUQ270
CAS No. :
1023817-10-8
Molecular Formula :
C8H9ClN2O2
Molecular Weight :
200.63

IUPAC Name:ethyl 2-(6-chloropyridazin-3-yl)acetate

Ethyl 2-(6-chloropyridazin-3-yl)acetate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$73.00Login to see priceIn stockInquiry
1g95%$186.00Login to see priceIn stockIn stock
5g95%$761.00Login to see priceIn stockIn stock
10g95%$1445.00Login to see priceIn stockIn stock
25g95%$2522.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameEthyl 2-(6-chloropyridazin-3-yl)acetate
IUPAC Nameethyl 2-(6-chloropyridazin-3-yl)acetate
MDL No.MFCD09881204
Molecular FormulaC8H9ClN2O2
Molecular Weight200.63
SMILESO=C(OCC)CC1=NN=C(Cl)C=C1
InChI KeyTZRXXSGPQOFJKS-UHFFFAOYSA-N
SynonymYQB81710 | ETHYL2-(6-CHLOROPYRIDAZIN-3-YL)ACETATE | PB34482 | SCHEMBL6666780 | AS-50666 | Ethyl 2-(6-Chloro-3-pyridazinyl)acetate | 1023817-10-8 | AKOS022176731 | ETHYL 2-(6-CHLOROPYRIDAZIN-3-YL)ACETATE | ETHYL 3-CHLOROPYRIDAZINE-6-ACETATE | P10834 | TZRX
CAS No.1023817-10-8
PubChem CID15661152

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACXPUQ270 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACXPUQ270 route product structure diagram
    ACXPUQ2701023817-10-8 In Stock
Inquiry

2. ACXPUQ270 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACXPUQ270 route product structure diagram
    ACXPUQ2701023817-10-8 In Stock
Inquiry

Comments (0)